Valneva SE (VALN) Amortization - Intangibles (2021 - 2026)
Valneva SE (VALN) reported Amortization - Intangibles of $1.4 million for Q1 2026, up 11.3% on a YoY basis from $1.3 million in Q1 2025, and up 0.58% sequentially from $1.4 million in Q4 2025.
Valneva SE (VALN) Amortization - Intangibles (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has 6 years of Amortization - Intangibles data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 11.3% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (up 7.92% YoY), and the FY2025 full-year result was $5.6 million, up 5.35% from the prior year.
- Amortization - Intangibles grew to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $5.3 billion in Q3 2022 to a low of -$5.4 billion in Q4 2022.
- A 5-year average of -$2.2 million and a median of $1.4 million in 2025 frame the typical range for Amortization - Intangibles.
- Peak annual rise in Amortization - Intangibles reached 100.02% in 2023, while the deepest fall reached 99.97% in 2023.
- Tracing VALN's Amortization - Intangibles over 5 years: stood at -$5.4 billion in 2022, then jumped by 100.02% to $1.2 million in 2023, then gained by 8.35% to $1.3 million in 2024, then grew by 8.93% to $1.4 million in 2025, then gained by 0.58% to $1.4 million in 2026.
- Business Quant data shows VALN's Amortization - Intangibles at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Valneva SE | 811.46 Mn | 688.23 Mn | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | -5.36 Bn |
| Sep 30, 2022 | 5.30 Bn |
| Jun 30, 2022 | 2.03 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Jun 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 1.81 Mn |